DK1560848T3 - PTPRK-immunogent peptid - Google Patents

PTPRK-immunogent peptid

Info

Publication number
DK1560848T3
DK1560848T3 DK03789032T DK03789032T DK1560848T3 DK 1560848 T3 DK1560848 T3 DK 1560848T3 DK 03789032 T DK03789032 T DK 03789032T DK 03789032 T DK03789032 T DK 03789032T DK 1560848 T3 DK1560848 T3 DK 1560848T3
Authority
DK
Denmark
Prior art keywords
ptprk
immunogenic peptide
diagnosis
cells
cancer immunotherapy
Prior art date
Application number
DK03789032T
Other languages
English (en)
Inventor
Chiara Castelli
Giorgio Parmiani
Original Assignee
Ist Naz Stud Cura Dei Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ist Naz Stud Cura Dei Tumori filed Critical Ist Naz Stud Cura Dei Tumori
Application granted granted Critical
Publication of DK1560848T3 publication Critical patent/DK1560848T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer
    • A61K2039/876—Skin, melanoma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK03789032T 2002-11-14 2003-11-12 PTPRK-immunogent peptid DK1560848T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002412A ITMI20022412A1 (it) 2002-11-14 2002-11-14 Peptidi immunogeni di ptprk.
PCT/EP2003/012638 WO2004043988A2 (en) 2002-11-14 2003-11-12 Ptprk immunogenic peptide

Publications (1)

Publication Number Publication Date
DK1560848T3 true DK1560848T3 (da) 2008-05-26

Family

ID=32310164

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03789032T DK1560848T3 (da) 2002-11-14 2003-11-12 PTPRK-immunogent peptid

Country Status (12)

Country Link
US (1) US20060159691A1 (da)
EP (1) EP1560848B1 (da)
JP (1) JP2006506064A (da)
AT (1) ATE383371T1 (da)
AU (1) AU2003293677A1 (da)
DE (1) DE60318608T2 (da)
DK (1) DK1560848T3 (da)
ES (1) ES2299748T3 (da)
HK (1) HK1076476A1 (da)
IT (1) ITMI20022412A1 (da)
PT (1) PT1560848E (da)
WO (1) WO2004043988A2 (da)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863755A (en) * 1993-04-21 1999-01-26 Max Planck Gessellschaft Nucleic acid encoding novel receptor-type phosphotyrosine phosphatase-κ

Also Published As

Publication number Publication date
DE60318608T2 (de) 2009-01-15
HK1076476A1 (en) 2006-01-20
ES2299748T3 (es) 2008-06-01
PT1560848E (pt) 2008-04-08
AU2003293677A1 (en) 2004-06-03
EP1560848A2 (en) 2005-08-10
ITMI20022412A1 (it) 2004-05-15
DE60318608D1 (de) 2008-02-21
JP2006506064A (ja) 2006-02-23
WO2004043988A8 (en) 2005-08-25
EP1560848B1 (en) 2008-01-09
US20060159691A1 (en) 2006-07-20
WO2004043988A3 (en) 2004-10-14
ATE383371T1 (de) 2008-01-15
WO2004043988A2 (en) 2004-05-27

Similar Documents

Publication Publication Date Title
CY1113044T1 (el) Παραλλαγματα αντιγονου αρχεγονων κυτταρων προστατη (psca) και υποαλληλουχιες εξ αυτων
PE20040554A1 (es) Vacunas que comprenden proteinas de fusion
CY1114855T1 (el) Αντισωματα και μορια που προερχονται απο αυτα που δεσμευονται στις πρωτεϊνες toy steap-1
CR8231A (es) Anticuerpos rg1 y uso de los mismos
HK1093014A1 (en) Microsome vaccine
EA200501206A1 (ru) Производные от сурвивина пептиды и их применение
WO2002064057A3 (en) Use of cell penetrating peptides to generate antitumor immunity
PT935607E (pt) Proteinas de fusao de classe ii do cph soluveis monovalentes e multivalentes, e suas utilizacoes
CY1107706T1 (el) Πεπτιδια ανταγωνιστες καρκινοεμβρυονικου αντιγονου (cea)
HK1074670A1 (en) Sets of digital antibodies directed against short epitopes, and methods using same
DK0810870T3 (da) Isolerede, MAGE-2-afledte tumorafstødelsesantigenpræcurserpeptider og anvendelse heraf
CY1106789T1 (el) Γενικος φορεας για στοχευση μοριων σε κυτταρα που εκφραζουν gb3 υποδοχεα
NO20030856D0 (no) Membranpenetrerende peptider og anvendelse av disse
CY1117746T1 (el) Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna
ATE457352T1 (de) Subtilisin-carlsberg-proteine mit verminderter immunogenität
GB2355983A (en) Method for producing or enhancing a T-cell response against a target cell using a complex comprising an HLA class 1 molecule and an attaching means
TR200102034T2 (tr) Anti kanser aşılaması için antikorların kullanılması
AU2003242535A1 (en) Improved polysaccharide and glycoconjugate vaccines
DE60118359D1 (de) Humanische pellino-polypeptide
DE69720065D1 (de) Therapeutische anwendungen von antigenen oder epitopen assoziert mit unvollständiger zellulärer peptidprozesierung , z.b.: exprimiert in rma-s zellen transfiziert mit b7-1 gen
AU7615900A (en) Isolated peptides which bind to mhc class ii molecules, and uses thereof
DK1560848T3 (da) PTPRK-immunogent peptid
AU2003241127A8 (en) Membrane-anchored beta2 microglobulin covalently linked to mhc class i peptide epitopes
GB0203419D0 (en) Peptide
AU2003245781A1 (en) Mhc class ii peptide epitope of 5t4 antigen